AC
MURA

Armistice Capital’s Mural Oncology MURA Stock Holding History

Armistice Capital’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,722,000
Closed -$2.17M – 245
2025
Q1 		$2.17M Buy
1,722,000
+22,000
+1% +$80.2K 0.03% 145
2024
Q4 		$5.47M Hold
1,700,000
– – 0.07% 120
2024
Q3 		$5.32M Buy
1,700,000
+12,000
+0.7% +$39.1K 0.09% 122
2024
Q2 		$5.3M Buy
1,688,000
+30,000
+2% +$111K 0.07% 112
2024
Q1 		$8.11M Hold
1,658,000
– – 0.11% 106
2023
Q4 		$9.82M Buy
+1,658,000
New +$6.67M 0.13% 90

Other funds holding MURA

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital's MURA Position: Q2 2025 in Review

Armistice Capital sold out of Mural Oncology (MURA) in Q2 2025, closing a stake of 1,722,000 shares — an estimated $2.17M sold.

Armistice Capital first reported a position in MURA in Q4 2023 and held it in 6 quarters. The position peaked at $9.82M in Q4 2023. 66 funds tracked by Wall St. Rank hold MURA as of Q2 2025.

  • Armistice Capital reported no remaining Mural Oncology position as of Q2 2025 after selling out during the quarter.
  • Armistice Capital sold 1,722,000 Mural Oncology shares in Q2 2025, an estimated $2.17M.
  • Armistice Capital first reported a position in Mural Oncology in Q4 2023 and held it in 6 quarters.
  • Armistice Capital's Mural Oncology position peaked at $9.82M in Q4 2023.
  • 66 funds tracked by Wall St. Rank held Mural Oncology as of Q2 2025.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.